Article Details

Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

Retrieved on: 2025-06-25 19:03:51

Tags for this article:

Click the tags to see associated articles and topics

Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD. View article details on hiswai:

Excerpt

... monoclonal antibody, tezepelumab. 1 Both antibodies showed similar binding affinity to TSLP—11.9 pM for solrikitug and 16.7 pM for tezepelumab ...

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo